Project Details
Description
SAFETY AND PHARMACOKINETICS OF ODM-208 IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
| Status | Active |
|---|---|
| Effective start/end date | 10/8/21 → 10/31/26 |
Funding
- Orion Corporation
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.